USPTO trademark

KITVI (BEZUCLASTINIB) TABLETS

Under examinationUSPTOWord and designClass 5

"KITVI (BEZUCLASTINIB) TABLETS" is a word and design mark owned by Cogent Biosciences, Inc., filed at the USPTO on August 21, 2026. It is under examination and covers class 5 (Pharmaceuticals).

Official USPTO record
KITVI (BEZUCLASTINIB) TABLETS trademark as filed
As filed with the USPTO
Status
Under examination
Since August 21, 2026
Filed
August 21, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50064173
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns KITVI (BEZUCLASTINIB) TABLETS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services KITVI (BEZUCLASTINIB) TABLETS is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About KITVI (BEZUCLASTINIB) TABLETS

Who owns the trademark "KITVI (BEZUCLASTINIB) TABLETS"?

The USPTO trademark "KITVI (BEZUCLASTINIB) TABLETS" (application 50064173) is owned by Cogent Biosciences, Inc.

What is the status of "KITVI (BEZUCLASTINIB) TABLETS"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull KITVI (BEZUCLASTINIB) TABLETS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_01a02995-14c9-726d-9d06-ddb0050cef7a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a02995-14c9-726d-9d06-ddb0050cef7a",
  "object": "trademark",
  "mark_text": "KITVI (BEZUCLASTINIB) TABLETS",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50064173",
  "filing_date": "2026-08-21",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Cogent Biosciences, Inc.",
      "entity_id": "ent_019f2860-84a6-734b-a70b-921eea6362c4"
    }
  ]
}